On Air Now

Listen

Listen Live Now » 95.5 FM Wausau, WI

Weather

Current Conditions(Wausau,WI 54403)

More Weather »
36° Feels Like: 31°
Wind: N 6 mph Past 24 hrs - Precip: 0.06”
Current Radar for Zip

Tonight

Partly Cloudy 24°

Tomorrow

Partly Cloudy 48°

Sat Night

Mostly Cloudy 28°

Alerts

Bayer seeks wider use for eye drug Eylea in Europe

The logo of Germany's largest drugmaker Bayer HealthCare Pharmaceuticals is pictured on the front of its building in Berlin April 28, 2011.
The logo of Germany's largest drugmaker Bayer HealthCare Pharmaceuticals is pictured on the front of its building in Berlin April 28, 2011.

FRANKFURT (Reuters) - German drugmaker Bayer said it filed for marketing approval in Europe for the use of eye drug Eylea as a treatment of diabetic macular oedema.

Bayer has said it expects Eylea, also known as VEGF Trap-Eye, to generate more than 1 billion euros ($1.35 billion) in peak annual sales.

The injection, which Bayer is co-developing with Regeneron, is already approved for other eye diseases. ($1 = 0.7392 euros)

(Reporting by Ludwig Burger; Editing by Christoph Steitz)

Comments